# Hillhurst Biopharmaceuticals, Inc.: funding, NIH (2024)

Registers read on November 19, 2026.

Hillhurst Biopharmaceuticals, Inc. (California) appears in 2 public registers SpecStream reads: 1 Form D filing and 10 NIH and NSF awards; the newest record is dated April 15, 2024, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 2
- Newest record: April 15, 2024
- State: California

## Form D filings (SEC)

1 Form D filing, newest September 26, 2023.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Form D](https://specstream.ai/data/form-d/company/hillhurst-biopharmaceuticals-inc-1994336) | September 26, 2023 | $1.8 million sold of $1.8 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1994336/000199433623000001/0001994336-23-000001-index.htm) |

- [Hillhurst Biopharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/hillhurst-biopharmaceuticals-inc-1994336)
- [SEC EDGAR filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1994336&type=D)

## NIH and NSF research awards

10 NIH and NSF awards, newest April 15, 2024.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [NIH](https://specstream.ai/data/research-funding/organization/hillhurst-biopharmaceuticals-inc-g5yjycgduzd7) | April 15, 2024 | HBI-002 for Cystic Fibrosis; $300 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10919079) |
| [NIH](https://specstream.ai/data/research-funding/organization/hillhurst-biopharmaceuticals-inc-g5yjycgduzd7) | September 1, 2022 | Oral N2O Therapy in Treating Acute Vaso-Occlusive Pain in Sickle Cell Disease; $2.1 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/10507724) |
| [NIH](https://specstream.ai/data/research-funding/organization/hillhurst-biopharmaceuticals-inc-g5yjycgduzd7) | September 1, 2022 | Oral N2O Therapy in Treating Acute Vaso-Occlusive Pain in Sickle Cell Disease; $728.1 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10699586) |
| [NIH](https://specstream.ai/data/research-funding/organization/hillhurst-biopharmaceuticals-inc-g5yjycgduzd7) | August 11, 2022 | Low Dose Oral Carbon Monoxide Therapeutic for Virus-Induced Lung Injury; $599.8 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10682510) |
| [NIH](https://specstream.ai/data/research-funding/organization/hillhurst-biopharmaceuticals-inc-g5yjycgduzd7) | September 20, 2021 | HBI-002 to Treat Parkinson’s Disease; $633.9 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10490383) |
| [NIH](https://specstream.ai/data/research-funding/organization/hillhurst-biopharmaceuticals-inc-g5yjycgduzd7) | September 1, 2021 | HBI-002 to Treat Diabetic Retinopathy; $1.9 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/11192356) |
| [NIH](https://specstream.ai/data/research-funding/organization/hillhurst-biopharmaceuticals-inc-g5yjycgduzd7) | September 1, 2021 | HBI-002 to Treat Diabetic Retinopathy; $299.9 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10323484) |
| [NIH](https://specstream.ai/data/research-funding/organization/hillhurst-biopharmaceuticals-inc-g5yjycgduzd7) | August 15, 2020 | HBI-002 to Prevent Anthracycline-Related Cardiotoxicity; $99.5 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10459735) |
| [NIH](https://specstream.ai/data/research-funding/organization/hillhurst-biopharmaceuticals-inc-g5yjycgduzd7) | May 16, 2020 | HBI-002 to Treat Ulcerative Colitis; $75.1 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10165710) |
| [NIH](https://specstream.ai/data/research-funding/organization/hillhurst-biopharmaceuticals-inc-g5yjycgduzd7) | April 7, 2016 | HBI-002 to Prevent Vaso-Occlusive Crises in Sickle Cell Disease; $3 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/11073056) |

- [Hillhurst Biopharmaceuticals, Inc.](https://specstream.ai/data/research-funding/organization/hillhurst-biopharmaceuticals-inc-g5yjycgduzd7)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (California), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in California

- [Air duct cleaning companies in California, United States](https://specstream.ai/data/businesses/air-duct-cleaning-companies/california-united-states)
- [Mattress manufacturing companies in California, United States](https://specstream.ai/data/businesses/mattress-manufacturing-companies/california-united-states)
- [Cardiology practices in California, United States](https://specstream.ai/data/businesses/cardiology-practices/california-united-states)
- [Preschools in California, United States](https://specstream.ai/data/businesses/preschools/california-united-states)
- [Elementary schools in California, United States](https://specstream.ai/data/businesses/elementary-schools/california-united-states)
- [Textile manufacturers in California, United States](https://specstream.ai/data/businesses/textile-manufacturers/california-united-states)
